Maternal and Child Health Journal

, Volume 18, Issue 1, pp 16–21 | Cite as

Increased Adherence to Prenatal Group B Streptococcal Screening Guidelines Through a Paired Electronic Reminder and Education Intervention

  • Kathy L. MacLaughlinEmail author
  • Gregory M. Garrison
  • Marc R. Matthews
  • Marcia L. O’Brien
  • Elizabeth Westby
  • Paul V. Targonski


The 2010 Centers for Disease Control and Prevention (CDC) update on perinatal group B streptococcal (GBS) prevention advises universal vaginal–rectal GBS screening of pregnant women in the 35th through 37th week of gestation. Because GBS colonization is transient, a test performed more than 5 weeks before delivery may not have sufficient negative predictive value to be clinically useful. Our objective was to increase rates of quality-improved, CDC-adherent GBS screening and decrease repeat screening. A reminder for maternal vaginal–rectal GBS testing was added to the physicians’ electronic ordering screen, and family medicine physicians and residents were educated about screening guidelines through standardized, in-person presentations. Retrospective chart review was performed before and after these interventions. Univariate or bivariate analysis was performed for demographic factors, timing of first screen, rates of CDC-adherent screening (the newly defined quality-improved screen and the usual screen), and rates of repeat and unnecessary screens. Multivariate analysis was performed with quality-improved and usual screening as dependent variables. Bivariate analysis showed that post-intervention rates of quality-improved screening increased from 30 to 62 % (P < .001), usual screening increased from 69 to 84 % (P = .005), and repeat GBS screening decreased from 20 to 8 % (P = .007). Multivariate analysis showed increased post-intervention odds of quality-improved screening [odds ratio (OR) 3.59; 95 % CI 2.07–6.34] and usual screening (OR 2.67; 95 % CI 1.40–5.25). Low-cost, reproducible quality improvement interventions (electronic order reminder, educational sessions) have the potential to increase guideline adherence for GBS screening in pregnant women and decrease repeat screening.


Group B streptococcal disease Guideline compliance Prenatal screening Quality improvement 



Centers for Disease Control and Prevention


group B streptococcal


Institute for Clinical Systems Improvement


vaginal and rectal



We appreciate and acknowledge the contributions of study team members Kyle J. Kircher, MD, MBA, Department of Family Medicine, Ms. Julie A. Maxson, Department of Family Medicine, and Ms. Vicki M. Clark, Practice-Based Research Network.

Conflict of interest



  1. 1.
    Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for disease control and prevention. MMWR Recommendations and reports, 1996 May 31;45(RR-7):1–24. Erratum in: MMWR Morb Mortal Wkly Rep 1996 9;45(31):679.Google Scholar
  2. 2.
    Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., et al. (2000). Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New England Journal of Medicine, 342(1), 15–20.CrossRefGoogle Scholar
  3. 3.
    Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. (2002). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recommendations and reports,. 16;51(RR-11):1–22.Google Scholar
  4. 4.
    Schrag, S. J., Zell, E. R., Lynfield, R., Roome, A., Arnold, K. E., Craig, A. S., et al. (2002). Active bacterial core surveillance team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine, 347(4), 233–239.CrossRefGoogle Scholar
  5. 5.
    Phares, C. R., Lynfield, R., Farley, M. M., Mohle-Boetani, J., Harrison, L. H., Petit, S., et al. (2008). Active bacterial core surveillance/emerging infections program network. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA, 299(17), 2056–2065.CrossRefGoogle Scholar
  6. 6.
    Verani JR, McGee L, Schrag SJ. (2010) Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. Recommendations and reports19;59(RR-10):1–36.Google Scholar
  7. 7.
    Yancey, M. K., Schuchat, A., Brown, L. K., Ventura, V. L., & Markenson, G. R. (1996). The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstetrics and Gynecology, 88(5), 811–815.CrossRefGoogle Scholar
  8. 8.
    Institute for Clinical Systems Improvement. Health care guideline: routine prenatal care [Internet]. 14th edition, 2010 Jul [cited 2011 Jan 27]. Available from:
  9. 9.
    Rodriguez, E., Raker, C. A., Paglia, M. J., & Anderson, B. L. (2010). Compliance with group B streptococcus testing prior to labor and delivery. American Journal of Perinatology, 27(6), 475–479.CrossRefGoogle Scholar
  10. 10.
    Faro S, Brehm B, Smith F, Mouzoon M, Greisinger A, Wehmanen O, et al. (2010) Screening for group B streptococcus: A private hospital’s experience. Infectious diseases in obstetrics and gynecology 2010. Epub 23 2010 Jun.Google Scholar
  11. 11.
    Bryant, A. S., Cheng, Y. W., & Caughey, A. B. (2011). Equality in obstetrical care: racial/ethnic variation in group B streptococcus screening. Maternal Child Health Journal, 15(8), 1160–1165. Erratum in: Maternal and Child Health J. 2011 Nov; 15(8): 1435.CrossRefGoogle Scholar
  12. 12.
    Cardenas, V., Davis, R. L., Hasselquist, M. B., Zavitkovsky, A., & Schuchat, A. (2002). Barriers to implementing the group B streptococcal prevention guidelines. Birth, 29(4), 285–290.CrossRefGoogle Scholar
  13. 13.
    Glass, N. E., Schulkin, J., Chamany, S., Riley, L. E., Schuchat, A., & Schrag, S. (2005). Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. Infectious diseases in obstetrics and gynecology, 13(1), 5–10.CrossRefGoogle Scholar
  14. 14.
    Kaambwa, B., Bryan, S., Gray, J., Milner, P., Daniels, J., Khan, K. S., et al. (2010). Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour. BJOG, 117(13), 1616–1627.CrossRefGoogle Scholar
  15. 15.
    Turrentine MA, Ramirez MM, Mastrobattista JM. (2009) Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization. Infectious diseases in obstetrics and gynecology, ;2009:934698. Epub 2009 Dec 13.Google Scholar
  16. 16.
    Grol, R. (2001). Successes and failures in the implementation of evidence-based guidelines for clinical practice. MedernalCare, 39(8 Suppl 2), II46–II54.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Kathy L. MacLaughlin
    • 1
    Email author
  • Gregory M. Garrison
    • 1
  • Marc R. Matthews
    • 1
  • Marcia L. O’Brien
    • 1
  • Elizabeth Westby
    • 1
  • Paul V. Targonski
    • 2
  1. 1.Department of Family MedicineMayo ClinicRochesterUSA
  2. 2.Division of Primary Care Internal Medicine, Mayo ClinicRochesterUSA

Personalised recommendations